CORTONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cortone, and what generic alternatives are available?
Cortone is a drug marketed by Merck and is included in two NDAs.
The generic ingredient in CORTONE is cortisone acetate. There are seventy-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cortisone acetate profile page.
Summary for CORTONE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 66 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CORTONE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CORTONE
US Patents and Regulatory Information for CORTONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Merck | CORTONE | cortisone acetate | INJECTABLE;INJECTION | 007110-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Merck | CORTONE | cortisone acetate | INJECTABLE;INJECTION | 007110-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Merck | CORTONE | cortisone acetate | TABLET;ORAL | 007750-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |